These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 21569906)

  • 1. Imaging surveillance of differentiated thyroid cancer.
    Johnson NA; LeBeau SO; Tublin ME
    Radiol Clin North Am; 2011 May; 49(3):473-87, vi. PubMed ID: 21569906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative surveillance of differentiated thyroid carcinoma: rationale, techniques, and controversies.
    Johnson NA; Tublin ME
    Radiology; 2008 Nov; 249(2):429-44. PubMed ID: 18936309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Taking of position in relationship to the protocol of the current treatment of thyroid nodules and differentiated thyroid cancer].
    Gómez Sáez JM
    Endocrinol Nutr; 2010 Oct; 57(8):370-5. PubMed ID: 20850397
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating thyroid cancer markers.
    Gupta M; Chia SY
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and treatment of differentiated thyroid carcinoma.
    Cox AE; LeBeau SO
    Radiol Clin North Am; 2011 May; 49(3):453-62, vi. PubMed ID: 21569904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroglobulin measurement vs iodine 131 total-body scan for follow-up of well-differentiated thyroid cancer.
    Aiello DP; Manni A
    Arch Intern Med; 1990 Feb; 150(2):437-9. PubMed ID: 2105703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
    Frasoldati A; Pesenti M; Gallo M; Caroggio A; Salvo D; Valcavi R
    Cancer; 2003 Jan; 97(1):90-6. PubMed ID: 12491509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.
    Whitley RJ; Ain KB
    Clin Lab Med; 2004 Mar; 24(1):29-47. PubMed ID: 15157556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood thyroglobulin and TSH receptor mRNA detection by RT-PCR in the follow-up of differentiated thyroid cancer patients.
    Torosian L; Manrique G; Alvarez B; Lago G; Roca R; Belzarena C
    Rev Esp Med Nucl; 2010; 29(3):109-13. PubMed ID: 20399540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.
    Wong R; Topliss DJ; Bach LA; Hamblin PS; Kalff V; Long F; Stockigt JR
    Intern Med J; 2009 Mar; 39(3):156-63. PubMed ID: 19383064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing concepts in the management of differentiated thyroid cancer.
    Intenzo CM; Jabbour S; Dam HQ; Capuzzi DM
    Semin Nucl Med; 2005 Oct; 35(4):257-65. PubMed ID: 16150246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of stimulated serum thyroglobulin levels for detecting persistent or recurrent differentiated thyroid cancer in high- and low-risk patients.
    Duren M; Siperstein AE; Shen W; Duh QY; Morita E; Clark OH
    Surgery; 1999 Jul; 126(1):13-9. PubMed ID: 10418587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirically treating high serum thyroglobulin levels.
    Mazzaferri EL
    J Nucl Med; 2005 Jul; 46(7):1079-88. PubMed ID: 16000275
    [No Abstract]   [Full Text] [Related]  

  • 16. Monitoring for Thyroid Cancer Recurrence.
    Peiris AN
    Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469905
    [No Abstract]   [Full Text] [Related]  

  • 17. [Postoperative treatment of differentiated thyroid carcinoma with intermediate recurrence risk].
    Yang X; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):378-81. PubMed ID: 23987482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic imaging and function tests in thyroid neoplasm].
    Yojin K
    Nihon Jibiinkoka Gakkai Kaiho; 1997 Nov; 100(11):1408-11. PubMed ID: 9480340
    [No Abstract]   [Full Text] [Related]  

  • 19. Regional and whole-body imaging in pediatric oncology.
    Goo HW
    Pediatr Radiol; 2011 May; 41 Suppl 1():S186-94. PubMed ID: 21523595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASO Author Reflections: The Ability of the AJCC 8th Edition to Predict Risk of Recurrence in Differentiated Thyroid Cancer.
    Gan T; Randle RW
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):672-673. PubMed ID: 31376039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.